![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Boston Scientific Corporation |
Information provided by: | Boston Scientific Corporation |
ClinicalTrials.gov Identifier: | NCT00133289 |
The ULTRA study will assess the difference in average ventricular voltage output for pacemaker patients randomized to Automatic Capture feature ON versus patients randomized to Automatic Capture feature OFF.
Condition | Intervention | Phase |
Bradycardia |
Device: Pacemaker with Automatic Capture |
Phase IV |
Genetics Home Reference related topics: | Brugada syndrome short QT syndrome |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Active Control, Parallel Assignment |
Official Title: | Ventricular Automatic Capture Assessment Study |
Estimated Enrollment: | 950 |
Study Start Date: | July 2005 |
Study Completion Date: | June 2007 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
United States, Massachusetts | |||||
Brigham and Women's Hospital | |||||
Boston, Massachusetts, United States, 02115 |
Boston Scientific Corporation |
Principal Investigator: | Bruce Koplan, MD | Brigham and Women's Hospital |
Study ID Numbers: | CR-CA-051205-B |
First Received: | August 19, 2005 |
Last Updated: | July 9, 2007 |
ClinicalTrials.gov Identifier: | NCT00133289 |
Health Authority: | United States: Institutional Review Board |
|
|
![]() |